WINTON GROUP Ltd Invests $3.92 Million in Veeva Systems Inc. $VEEV

WINTON GROUP Ltd purchased a new position in Veeva Systems Inc. (NYSE:VEEV) in the 4th quarter, Holdings Channel reports. The firm purchased 17,543 shares of the technology company’s stock, valued at approximately $3,916,000.

Several other hedge funds have also recently modified their holdings of VEEV. Norges Bank purchased a new position in shares of Veeva Systems in the fourth quarter worth $332,412,000. Alphinity Investment Management Pty Ltd purchased a new stake in Veeva Systems during the third quarter valued at $422,241,000. Durable Capital Partners LP purchased a new stake in Veeva Systems during the second quarter valued at $281,351,000. AQR Capital Management LLC increased its position in Veeva Systems by 31.2% during the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock valued at $706,078,000 after acquiring an additional 574,164 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in Veeva Systems by 3.1% during the third quarter. Vanguard Group Inc. now owns 15,429,231 shares of the technology company’s stock valued at $4,596,522,000 after acquiring an additional 457,806 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. TD Cowen reiterated a “buy” rating on shares of Veeva Systems in a research report on Thursday. Stifel Nicolaus reduced their price objective on Veeva Systems from $245.00 to $230.00 and set a “buy” rating for the company in a research report on Thursday. Evercore reiterated an “outperform” rating and set a $185.00 price objective on shares of Veeva Systems in a research report on Thursday. Barclays reduced their price objective on Veeva Systems from $250.00 to $235.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, BTIG Research reiterated a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research report on Thursday. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $250.96.

Veeva Systems Price Performance

Shares of VEEV stock opened at $172.96 on Friday. The company has a market capitalization of $28.25 billion, a price-to-earnings ratio of 30.83, a PEG ratio of 0.76 and a beta of 0.95. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50. The company’s fifty day moving average price is $166.17 and its 200-day moving average price is $195.74.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. The firm had revenue of $882.95 million during the quarter, compared to analyst estimates of $857.73 million. Veeva Systems had a return on equity of 13.89% and a net margin of 28.37%.The business’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Equities research analysts expect that Veeva Systems Inc. will post 6.46 earnings per share for the current fiscal year.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the sale, the director directly owned 3,253 shares of the company’s stock, valued at $506,296.92. This trade represents a 18.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by company insiders.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva beat Q1 earnings and revenue estimates, with EPS of $2.24 and revenue of $882.9 million, while also raising its fiscal 2027 outlook. Veeva Systems beats estimates on AI progress
• Positive Sentiment: Management highlighted AI momentum, including Falcon AI agents, CRM migration wins, and the Ostro acquisition, suggesting new growth drivers beyond the core platform. Veeva Systems Q1 Earnings Call Highlights AI Push & Higher Outlook
• Positive Sentiment: Several brokers remained constructive, including Barclays, Oppenheimer, RBC, Needham, BTIG, and Robert W. Baird, many of which kept buy/outperform ratings and elevated price targets. Veeva Systems (VEEV) Receives a Buy from Barclays
• Neutral Sentiment: Citigroup raised its target to $190 and maintained a neutral stance, while UBS and Canaccord also trimmed targets but stayed at neutral/hold, reflecting a more mixed Street view. Analyst updates
• Negative Sentiment: Despite the beat-and-raise quarter, the stock sold off as investors likely questioned how much of the AI optimism is already priced in and whether legacy CRM migration dynamics could pressure growth. Is Veeva Stock Undervalued At $170?
• Negative Sentiment: Goldman Sachs cut its price target to $165 and kept a sell rating, adding to the cautious tone around the name. Veeva Systems price target lowered by Goldman Sachs

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.